Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

@article{Hanahan1996PatternsAE,
  title={Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis},
  author={D. Hanahan and J. Folkman},
  journal={Cell},
  year={1996},
  volume={86},
  pages={353-364}
}
We wish to thank Jeff Arbeit, Karen Smith-McCune, Noel Weidner, Ella Bossy-Wetzel, and Christine Jolicoeur for providing the tissue sections used to prepare Figure 3Figure 3; Noel Bouck, Karen Smith-McCune, David Olson, Dowdy Jackson, and Jeff Arbeit for comments on the manuscript; and Wendy Gee and Terry Schoop of BioMed Arts (San Francisco) for artwork. The work from the authors' laboratories reviewed herein was supported by grants from the National Cancer Institute. 
Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1.
TLDR
This issue of Cancer Cell, Watnick and colleagues use a genetically defined tumor model system to determine the link between ras, myc, and angiogenesis and identify Thrombospondin-1 as being the critical regulator ofAngiogenesis in this system. Expand
The Hallmarks of Cancer
TLDR
This work has been supported by the Department of the Army and the National Institutes of Health, and the author acknowledges the support and encouragement of the National Cancer Institute. Expand
Manipulating angiogenesis. From basic science to the bedside.
  • M. Pepper
  • Biology, Medicine
  • Arteriosclerosis, thrombosis, and vascular biology
  • 1997
TLDR
By manipulating angiogenesis either positively or negatively, considerable therapeutic benefit can now be envisaged in physiological and pathological settings in which neovascularization is a prominent component. Expand
Neoplastic Non-Angiogenic Growth by Means of Vascular Co-Option
TLDR
The observation that cancer cells can exploit pre-existing vessels provides a new aspect of the interaction between host and tumors, sheds new light on the biology of the latter and has implications for resistance to antiangiogenic drugs and development of new vascular targeting strategies. Expand
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.
TLDR
A striking correlation between highly genetically heterogeneous bFGF- or VEGF-induced angiogenesis and intrinsic CEC or CEP levels measured by flow cytometry is shown, among eight different inbred mouse strains. Expand
Inducing angiogenesis a hallmark too far
Copyright: ©2015 Pezzella F. This is an openaccess article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction inExpand
Is Syndecan-2 a Key Angiogenic Element?
TLDR
This work reports its involvement in the reorganization of the cytoskeleton and proposes a key role for this proteoglycan as an adaptor protein, able to work in cooperation with the integrins in the formation of new blood vessels. Expand
No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer.
TLDR
A novel way to inhibit angiogenesis is postulate by removal of the matrix through specific and localised overstimulation of the plasminogen activation system. Expand
RAS Oncogenes and Tumor-Vascular Interface
TLDR
In 1981, the laboratory led by Robert Weinberg succeeded in transferring DNA sequences from human cancer cells to immortalized murine fibroblasts, causing their overt malignant transformation. Expand
From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
  • M. Rio
  • Biology, Medicine
  • Biochimie
  • 2005
TLDR
Review of the literature shows that ST3 is an active partner of cancer cells along the whole natural cancer history, and is essential for optimal tumor development as it reduces death ofcancer cells invading adjacent connective tissues at the primary tumor site. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 141 REFERENCES
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.
TLDR
Transfection assays indicate that, in fibroblasts, wild-type p53 inhibits angiogenesis through regulation of TSP-1 synthesis. Expand
Clinical Applications of Research on Angiogenesis
TLDR
The realization that tumor growth requires new blood vessels and the identification of chemical factors that mediate angiogenesis have broadened the understanding of pathologic processes and opened new avenues to the diagnosis and treatment of these diseases. Expand
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
TLDR
In this multistep tumorigenesis pathway of dermal fibrosarcomas, there appears to be a discrete switch to the angiogenic phenotype that correlates with the export of bFGF, a knownAngiogenic factor. Expand
Angiogenesis: models and modulators.
TLDR
This work presents and discusses how the available models most closely represent phases of in vivo angiogenesis and the development of vessel patency, generated by a coalescing of intracellular vacuoles. Expand
Angiostatin induces and sustains dormancy of human primary tumors in mice
TLDR
It is shown that systemic administration of human angiostatin potently inhibits the growth of three human and three murine primary carcinomas in mice, the first demonstration of dormancy therapy, a novel anticancer strategy in which malignant tumors are regressed by prolonged blockade of angiogenesis. Expand
Tumor angiogenesis.
TLDR
Much work remains to be done before it will be possible to understand the regulatory systems that govern capillary density in normal tissues; the factors that maintain the viability of microvascular endothelium; the development of the vascular system itself; and the mechanism by which vascular regression occurs, both in the embryo and in the postnatal organism. Expand
Angiogenesis inhibition: a review.
TLDR
An effort is made to place the many different approaches to anti-angiogenesis research into a comprehensible structure, in order to identify problems of evaluation and interpretation, thereby providing a clearer basis for determining promising and needed directions for further investigation. Expand
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
TLDR
The biological relevance of the VEGF/Flk-1 receptor/ligand system for angiogenesis is investigated using a retrovirus encoding a dominant-negative mutant of the Flk- 1/VEGF receptor to infect endothelial target cells in vivo, and tumour growth is prevented in nude mice. Expand
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
TLDR
It is shown that the inhibition of metastases by a primary mouse tumor is mediated, at least in part, by angiostatin, and a corresponding fragment of human plasminogen has similar activity. Expand
Consequences of angiogenesis for tumor progression, metastasis and cancer therapy.
TLDR
Distinct biological features expressed by tumor-associated vasculature may serve as potential prognostic markers of disease progression as well as novel targets for therapeutic intervention. Expand
...
1
2
3
4
5
...